Fast growing neuroscience company featured by Nature as a top academic spinout, recognized for developing non-psychedelic analogs to treat psychiatric and neurological conditions BOSTON, Sept. 13, 2022 /PRNewswire/ — Delix Therapeutics (the “Company”), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological conditions, has been named to Nature…


Previous articlePT355 – Ifetayo Harvey – The Drug War, Caregiving, and Blue Sky Thinking
Next articleSmall Pharma Enters Into Automatic Share Purchase Plan